Yasuhiro Ogura

Author PubWeight™ 78.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Living donor liver transplantation: the Asian perspective. Transplantation 2014 2.13
2 Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007 2.09
3 Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010 1.82
4 Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant 2005 1.70
5 Left-sided grafts for living-donor liver transplantation and split grafts for deceased-donor liver transplantation: their impact on long-term survival. Clin Res Hepatol Gastroenterol 2011 1.63
6 Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. World J Gastroenterol 2010 1.57
7 Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition 2012 1.46
8 Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003 1.45
9 Living-donor liver transplantation with monosegments. Transplantation 2003 1.45
10 Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007 1.27
11 CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem 2012 1.26
12 Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 2006 1.20
13 Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl 2003 1.19
14 IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant 2005 1.14
15 Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007 1.11
16 Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010 1.10
17 Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 2003 1.09
18 Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 2008 1.08
19 "Small-for-size graft" and "small-for-size syndrome" in living donor liver transplantation. Yonsei Med J 2004 1.05
20 Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005 1.03
21 Impact of right lobe with middle hepatic vein graft in living-donor liver transplantation. Am J Transplant 2005 1.02
22 Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J 2012 1.02
23 Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation 2012 1.01
24 Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010 0.96
25 Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. World J Gastroenterol 2006 0.95
26 CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation. Pharmacogenetics 2004 0.94
27 End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004 0.93
28 Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients. Clin Pharmacol Ther 2006 0.92
29 Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation. Hepatol Res 2012 0.92
30 Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. Drug Metab Dispos 2009 0.92
31 Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients. Clin Pharmacol Ther 2005 0.92
32 Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl 2010 0.91
33 Living-related liver transplantation for Alagille syndrome. Transplantation 2003 0.88
34 Appleby operation for pancreatic body-tail carcinoma: report of three cases. Surg Today 2003 0.87
35 Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center. Liver Transpl 2006 0.87
36 Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing. Liver Transpl 2006 0.86
37 De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation. Antivir Ther 2011 0.86
38 Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan. Clin Transplant 2010 0.85
39 Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation. Transpl Int 2009 0.85
40 The role of apheresis therapy in living donor liver transplantation. Ther Apher Dial 2004 0.85
41 Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome. Liver Transpl 2006 0.85
42 Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab Pharmacokinet 2006 0.84
43 NK cells and transplantation. Transpl Immunol 2002 0.84
44 A case of inflammatory pseudotumor of the liver hilum successfully treated with aggressive hepatectomy. J Pediatr Surg 2003 0.84
45 Effects of post-transplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation. World J Surg 2012 0.83
46 Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts. Transplantation 2004 0.83
47 A case of adult-to-adult living donor liver transplantation using right and left lateral lobe grafts from 2 donors. Surgery 2002 0.83
48 Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients. Liver Transpl 2014 0.83
49 Impact of pretransplant nutritional status in patients undergoing liver transplantation. Hepatogastroenterology 2011 0.83
50 Living-donor liver transplantation for situs inversus: 2 case reports. J Pediatr Surg 2005 0.83
51 Successful liver transplantation for congenital absence of the portal vein complicated by intrapulmonary shunt and brain abscess. J Pediatr Surg 2005 0.82
52 How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results. Clin Transplant 2012 0.82
53 Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy. Hepatogastroenterology 2005 0.82
54 Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation. Transpl Immunol 2012 0.82
55 MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients. Pharm Res 2009 0.82
56 Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res 2012 0.81
57 Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation 2009 0.81
58 Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease. J Pediatr Surg 2004 0.81
59 Variations in biliary anatomy associated with trifurcated portal vein in right-lobe living-donor liver transplantation. Transplantation 2005 0.81
60 Apheresis therapy for living-donor liver transplantation: experience for apheresis use for living-donor liver transplantation at Kyoto University. Ther Apher 2002 0.81
61 Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepatogastroenterology 2011 0.81
62 Pediatric orthotopic living-donor liver transplantation cures pulmonary hypertension caused by Abernethy malformation type Ib. Pediatr Transplant 2011 0.80
63 Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan. World J Gastroenterol 2011 0.80
64 Standard hepatic vein reconstruction with patch plasty using the native portal vein in adult living donor liver transplantation. Liver Transpl 2012 0.80
65 Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study. Drug Metab Pharmacokinet 2009 0.79
66 Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection. Surgery 2011 0.79
67 Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5. Drug Metab Pharmacokinet 2008 0.79
68 Can children catch up in growth after living donor liver transplantation? Liver Transpl 2010 0.79
69 Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation. Eur J Clin Pharmacol 2011 0.78
70 How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? Noninvasive measurement of indocyanine green elimination rate. Surg Innov 2013 0.78
71 Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT. Transpl Int 2009 0.77
72 Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation. Transpl Int 2009 0.77
73 Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2008 0.77
74 Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors. Transplantation 2014 0.77
75 Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases. Transpl Int 2010 0.77
76 Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures. Surg Today 2012 0.76
77 Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation. J Pharmacol Exp Ther 2008 0.76
78 Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation. Surg Today 2014 0.76
79 Monosegmental living-donor liver transplantation for infantile hepatic hemangioendothelioma. J Pediatr Surg 2003 0.76
80 Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res 2013 0.76
81 The technical pitfalls of duct-to-duct biliary reconstruction in pediatric living-donor left-lobe liver transplantation: the impact of stent placement. Pediatr Transplant 2007 0.76
82 The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation. Clin Transplant 2008 0.76
83 Successful surgical ligation under intraoperative portal vein pressure monitoring of a large portosystemic shunt presenting as an intrapulmonary shunt: report of a case. Surg Today 2004 0.75
84 Liver transplantation for congenital biliary dilatation: a single-center experience. Dig Surg 2010 0.75
85 Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation. PLoS One 2013 0.75
86 Section 7. A new therapeutic strategy on portal flow modulation that increases donor safety with good recipient outcomes. Transplantation 2014 0.75
87 Toxicokinetics of perfluoroalkyl carboxylic acids with different carbon chain lengths in mice and humans. J Occup Health 2014 0.75
88 Successful stent placement for hepatic venous outflow obstruction in pediatric living donor liver transplantation, including a case series review. Pediatr Transplant 2008 0.75
89 Role of bcl-2 mRNA in homeostatic proliferation in circulating T-cells in human liver transplant patients after T-cell depletion. J Surg Res 2005 0.75
90 Quantitative survival model for short-term survival after adult-to-adult living donor liver transplantation. Liver Transpl 2006 0.75
91 Use of recipient's left colic artery for arterial reconstruction during liver transplantation in Alagille syndrome with vasculopathy: a case report. Transplantation 2012 0.75
92 Liver transplantation for severe hepatitis in patients with common variable immunodeficiency. Pediatr Transplant 2011 0.75
93 Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases. Intern Med 2014 0.75
94 Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence? World J Surg 2011 0.75
95 Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma. Hepatogastroenterology 2015 0.75
96 Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer. Hepatogastroenterology 2005 0.75
97 Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bile. Drug Metab Pharmacokinet 2008 0.75
98 Subcapsular hematoma after right-lobe living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2004 0.75
99 Density-independent high moisture content measurement using phase shifts at two microwave frequencies. J Microw Power Electromagn Energy 2010 0.75
100 Liver Transplantation in Adults with Acute Liver Failure: A Single Center Experience over A Period of 15 Years. Hepatogastroenterology 2015 0.75
101 The rare insertion of b4 with trifurcated portal vein in live donor. Transplantation 2010 0.75
102 Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation 2002 0.75